{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:37:56Z","timestamp":1788316676908,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,11]]},"DOI":"10.7759\/cureus.96576","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:17:32Z","timestamp":1762874252000},"source":"Crossref","is-referenced-by-count":1,"title":["Mixed-Phenotype Acute Leukemia Transforming Into Acute Myelomonocytic Leukemia (AML M4): A Case Report and Therapeutic Challenges"],"prefix":"10.7759","author":[{"given":"Bakr","family":"Alhayek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamim","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Gummalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911259","article-title":"Genomic landscape of mixed-phenotype acute leukemia","volume":"23","author":"Hennawi M","year":"2022","unstructured":"Hennawi M, Pakasticali N, Tashkandi H, Hussaini M. Genomic landscape of mixed-phenotype acute leukemia. Int J Mol Sci. 2022, 23:11259. 10.3390\/ijms231911259","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3297-6","article-title":"An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL)","volume":"97","author":"Khan M","year":"2018","unstructured":"Khan M, Siddiqi R, Naqvi K. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL). Ann Hematol. 2018, 97:945-53. 10.1007\/s00277-018-3297-6","journal-title":"Ann Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04924-z","article-title":"Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes","volume":"9","author":"Takahashi K","year":"2018","unstructured":"Takahashi K, Wang F, Morita K, et al.. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Nat Commun. 2018, 9:2670. 10.1038\/s41467-018-04924-z","journal-title":"Nat Commun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01468","article-title":"Initial diagnostic work-up of acute leukemia: ASCO clinical practice guideline endorsement of the College of American Pathologists and American Society of Hematology guideline","volume":"37","author":"de Haas V","year":"2019","unstructured":"de Haas V, Ismaila N, Advani A, et al.. Initial diagnostic work-up of acute leukemia: ASCO clinical practice guideline endorsement of the College of American Pathologists and American Society of Hematology guideline. J Clin Oncol. 2019, 37:239-53. 10.1200\/JCO.18.01468","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-551465","article-title":"How I treat mixed-phenotype acute leukemia","volume":"125","author":"Wolach O","year":"2015","unstructured":"Wolach O, Stone RM. How I treat mixed-phenotype acute leukemia. Blood. 2015, 125:2477-85. 10.1182\/blood-2014-10-551465","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander TB","year":"2018","unstructured":"Alexander TB, Gu Z, Iacobucci I, et al.. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018, 562:373-9. 10.1038\/s41586-018-0436-0","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100466","article-title":"Fifth edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: acute lymphoblastic leukemias, mixed-phenotype acute leukemias, myeloid\/lymphoid neoplasms with eosinophilia, dendritic\/histiocytic neoplasms, and genetic tumor syndromes","volume":"37","author":"Choi JK","year":"2024","unstructured":"Choi JK, Xiao W, Chen X, et al.. Fifth edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: acute lymphoblastic leukemias, mixed-phenotype acute leukemias, myeloid\/lymphoid neoplasms with eosinophilia, dendritic\/histiocytic neoplasms, and genetic tumor syndromes. Mod Pathol. 2024, 37:100466. 10.1016\/j.modpat.2024.100466","journal-title":"Mod Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081974","article-title":"Mixed-phenotype acute leukemia: clinical diagnosis and therapeutic strategies","volume":"10","author":"George BS","year":"2022","unstructured":"George BS, Yohannan B, Gonzalez A, Rios A. Mixed-phenotype acute leukemia: clinical diagnosis and therapeutic strategies. Biomedicines. 2022, 10:1974. 10.3390\/biomedicines10081974","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/BS9.0000000000000220","article-title":"A shadow in the treatment of acute leukemia: lineage switch","volume":"7","author":"Zhou Q","year":"2025","unstructured":"Zhou Q, Wang Y. A shadow in the treatment of acute leukemia: lineage switch. Blood Sci. 2025, 7:e00220. 10.1097\/BS9.0000000000000220","journal-title":"Blood Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52317-2","article-title":"Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia","volume":"15","author":"Peretz CA","year":"2024","unstructured":"Peretz CA, Kennedy VE, Walia A, et al.. Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia. Nat Commun. 2024, 15:8191. 10.1038\/s41467-024-52317-2","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283705","article-title":"Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies","volume":"109","author":"Bataller A","year":"2024","unstructured":"Bataller A, Abuasab T, McCall D, et al.. Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies. Haematologica. 2024, 109:293-7. 10.3324\/haematol.2023.283705","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.galenos.2021.2021.0280","article-title":"Dicentric (7;12)(p11;p11) in T\/myeloid mixed-phenotype acute leukemia","volume":"38","author":"Gajendra S","year":"2021","unstructured":"Gajendra S, Gore AR, Sood N, Bhargav M. Dicentric (7;12)(p11;p11) in T\/myeloid mixed-phenotype acute leukemia. Turk J Haematol. 2021, 38:239-41. 10.4274\/tjh.galenos.2021.2021.0280","journal-title":"Turk J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-009-0268-7","article-title":"Monosomies 7p and 12p and FLT3 internal tandem duplication: possible markers for diagnosis of T\/myeloid biphenotypic acute leukemia and its clonal evolution","volume":"89","author":"Matsumoto Y","year":"2009","unstructured":"Matsumoto Y, Taki T, Fujimoto Y, et al.. Monosomies 7p and 12p and FLT3 internal tandem duplication: possible markers for diagnosis of T\/myeloid biphenotypic acute leukemia and its clonal evolution. Int J Hematol. 2009, 89:352-8. 10.1007\/s12185-009-0268-7","journal-title":"Int J Hematol"},{"key":"ref14","article-title":"t(7;12)(p12;p13) IKZF1\/ETV6","volume":"7","author":"Dessen P","year":"2018","unstructured":"Dessen P, Huret JL. t(7;12)(p12;p13) IKZF1\/ETV6. Atlas Genet Cytogenet Oncol Haematol. 2018, 7:2025.","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"ref15","article-title":"dic(7;12)(p10-p12;p11-p13)","author":"Zamecnikova A","year":"2018","unstructured":"Zamecnikova A. dic(7;12)(p10-p12;p11-p13). Atlas Genet Cytogenet Oncol Haematol. 2018, 01.","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13923","article-title":"To B- or not to B-: a review of lineage switched acute leukemia","volume":"44 Suppl 1","author":"Kurzer JH","year":"2022","unstructured":"Kurzer JH, Weinberg OK. To B- or not to B-: a review of lineage switched acute leukemia. Int J Lab Hematol. 2022, 44 Suppl 1:64-70. 10.1111\/ijlh.13923","journal-title":"Int J Lab Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb04515.x","article-title":"Monosomy 7 in multilineage and acute lymphoblastic leukaemia","volume":"79","author":"Paietta E","year":"1991","unstructured":"Paietta E, Gucalp R, Wiernik PH. Monosomy 7 in multilineage and acute lymphoblastic leukaemia. Br J Haematol. 1991, 79:152-5. 10.1111\/j.1365-2141.1991.tb04515.x","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(99)00008-9","article-title":"Lineage switch in childhood leukemia with monosomy 7 and reverse of lineage switch in severe combined immunodeficient mice","volume":"27","author":"Fujisaki H","year":"1999","unstructured":"Fujisaki H, Hara J, Takai K, et al.. Lineage switch in childhood leukemia with monosomy 7 and reverse of lineage switch in severe combined immunodeficient mice. Exp Hematol. 1999, 27:826-33. 10.1016\/S0301-472X(99)00008-9","journal-title":"Exp Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.87163","article-title":"The emergence of subclones following initial chemotherapy in mixed phenotype acute leukemia","volume":"17","author":"Murao T","year":"2025","unstructured":"Murao T, Yamane Y, Kiyota M, et al.. The emergence of subclones following initial chemotherapy in mixed phenotype acute leukemia. Cureus. 2025, 17:e87163. 10.7759\/cureus.87163","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16244136","article-title":"Acute myeloid leukaemia and acute lymphoblastic leukaemia classification and metabolic characteristics for informing and advancing treatment","volume":"16","author":"Wemyss C","year":"2024","unstructured":"Wemyss C, Jones E, Stentz R, Carding SR. Acute myeloid leukaemia and acute lymphoblastic leukaemia classification and metabolic characteristics for informing and advancing treatment. Cancers (Basel). 2024, 16:4136. 10.3390\/cancers16244136","journal-title":"Cancers (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026655","article-title":"Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia","volume":"146","author":"Silbert SK","year":"2025","unstructured":"Silbert SK, Rankin AW, Hoang CN, et al.. Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia. Blood. 2025, 146:437-55. 10.1182\/blood.2024026655","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade D","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, et al.. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010, 116:354-65. 10.1182\/blood-2009-11-254441","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/382186","article-title":"The relationship between clinical feature, complex immunophenotype, chromosome karyotype, and outcome of patients with acute myeloid leukemia in China","volume":"2015","author":"Ding B","year":"2015","unstructured":"Ding B, Zhou L, Jiang X, et al.. The relationship between clinical feature, complex immunophenotype, chromosome karyotype, and outcome of patients with acute myeloid leukemia in China. Dis Markers. 2015, 2015:382186. 10.1155\/2015\/382186","journal-title":"Dis Markers"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2023.107309","article-title":"Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: a study from the Bone Marrow Pathology Group","volume":"130","author":"Kirtek T","year":"2023","unstructured":"Kirtek T, Chen W, Laczko D, et al.. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: a study from the Bone Marrow Pathology Group. Leuk Res. 2023, 130:107309. 10.1016\/j.leukres.2023.107309","journal-title":"Leuk Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.064485","article-title":"Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification","volume":"97","author":"Yan L","year":"2012","unstructured":"Yan L, Ping N, Zhu M, et al.. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica. 2012, 97:1708-12. 10.3324\/haematol.2012.064485","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779405","article-title":"Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia","volume":"130","author":"Stein EM","year":"2017","unstructured":"Stein EM, DiNardo CD, Pollyea DA, et al.. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia. Blood. 2017, 130:722-31. 10.1182\/blood-2017-04-779405","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014901","article-title":"Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed\/refractory AML: a randomized phase 3 trial","volume":"141","author":"de Botton S","year":"2023","unstructured":"de Botton S, Montesinos P, Schuh AC, et al.. Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed\/refractory AML: a randomized phase 3 trial. Blood. 2023, 141:156-67. 10.1182\/blood.2021014901","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/1750743X.2025.2527018","article-title":"Chemotherapy-free treatment of B-lymphoid\/myeloid mixed phenotype acute leukemia: two case reports and literature review","volume":"17","author":"Wang YF","year":"2025","unstructured":"Wang YF, Dai JY, Li MY, Jiang T. Chemotherapy-free treatment of B-lymphoid\/myeloid mixed phenotype acute leukemia: two case reports and literature review. Immunotherapy. 2025, 17:639-47. 10.1080\/1750743X.2025.2527018","journal-title":"Immunotherapy"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8811673","article-title":"Venetoclax and decitabine for T\/myeloid mixed-phenotype acute leukemia not otherwise specified (MPAL NOS)","volume":"2020","author":"Klocke H","year":"2020","unstructured":"Klocke H, Dong ZM, O'Brien C, et al.. Venetoclax and decitabine for T\/myeloid mixed-phenotype acute leukemia not otherwise specified (MPAL NOS). Case Rep Hematol. 2020, 2020:8811673. 10.1155\/2020\/8811673","journal-title":"Case Rep Hematol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000519882","article-title":"Venetoclax in combination with hypomethylating agents for the treatment of treatment-naive B\/myeloid mixed-phenotype acute leukemia and relapsed\/refractory acute myeloid leukemia: a report of 3 cases","volume":"67","author":"Wang N","year":"2022","unstructured":"Wang N, He J, Liu F. Venetoclax in combination with hypomethylating agents for the treatment of treatment-naive B\/myeloid mixed-phenotype acute leukemia and relapsed\/refractory acute myeloid leukemia: a report of 3 cases. Chemotherapy. 2022, 67:178-82. 10.1159\/000519882","journal-title":"Chemotherapy"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036397","article-title":"Favorable response of a patient with primary B\/myeloid mixed phenotype acute Leukemia to CD19-CAR-T: case report and literature review","volume":"102","author":"Wang L","year":"2023","unstructured":"Wang L, Pang Y, Fang C, et al.. Favorable response of a patient with primary B\/myeloid mixed phenotype acute Leukemia to CD19-CAR-T: case report and literature review. Medicine (Baltimore). 2023, 102:e36397. 10.1097\/MD.0000000000036397","journal-title":"Medicine (Baltimore)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03228-8","article-title":"Fratricide-resistant CD7-CAR T cells in T-ALL","volume":"30","author":"Oh BL","year":"2024","unstructured":"Oh BL, Shimasaki N, Coustan-Smith E, et al.. Fratricide-resistant CD7-CAR T cells in T-ALL. Nat Med. 2024, 30:3687-96. 10.1038\/s41591-024-03228-8","journal-title":"Nat Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14799","article-title":"Preclinical and clinical advances in dual-target chimeric antigen receptor therapy for hematological malignancies","volume":"112","author":"Guo Z","year":"2021","unstructured":"Guo Z, Tu S, Yu S, et al.. Preclinical and clinical advances in dual-target chimeric antigen receptor therapy for hematological malignancies. Cancer Sci. 2021, 112:1357-68. 10.1111\/cas.14799","journal-title":"Cancer Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-009-0007-3","article-title":"Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse","volume":"15","author":"Imataki O","year":"2010","unstructured":"Imataki O, Ohnishi H, Yamaoka G, et al.. Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse. Int J Clin Oncol. 2010, 15:112-15. 10.1007\/s10147-009-0007-3","journal-title":"Int J Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2011.26.6.829","article-title":"Lineage switch at relapse of childhood acute leukemia: a report of four cases","volume":"26","author":"Park M","year":"2011","unstructured":"Park M, Koh KN, Kim BE, et al.. Lineage switch at relapse of childhood acute leukemia: a report of four cases. J Korean Med Sci. 2011, 26:829-31. 10.3346\/jkms.2011.26.6.829","journal-title":"J Korean Med Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23266","article-title":"Lineage switch in childhood acute leukemia: an unusual event with poor outcome","volume":"87","author":"Rossi JG","year":"2012","unstructured":"Rossi JG, Bernasconi AR, Alonso CN, et al.. Lineage switch in childhood acute leukemia: an unusual event with poor outcome. Am J Hematol. 2012, 87:890-7. 10.1002\/ajh.23266","journal-title":"Am J Hematol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.753450","article-title":"Lineage switch from pro-B acute lymphoid leukemia to acute myeloid leukemia in a case with t(12;17)(p13;q11)\/TAF15-ZNF384 rearrangement","volume":"54","author":"Grammatico S","year":"2013","unstructured":"Grammatico S, Vitale A, La Starza R, et al.. Lineage switch from pro-B acute lymphoid leukemia to acute myeloid leukemia in a case with t(12;17)(p13;q11)\/TAF15-ZNF384 rearrangement. Leuk Lymphoma. 2013, 54:1802-5. 10.3109\/10428194.2012.753450","journal-title":"Leuk Lymphoma"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3050-6","article-title":"Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy","volume":"96","author":"Balducci E","year":"2017","unstructured":"Balducci E, Nivaggioni V, Boudjarane J, et al.. Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy. Ann Hematol. 2017, 96:1579-81. 10.1007\/s00277-017-3050-6","journal-title":"Ann Hematol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.89","article-title":"Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A\/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis","volume":"7","author":"Haddox CL","year":"2017","unstructured":"Haddox CL, Mangaonkar AA, Chen D, et al.. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A\/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis. Blood Cancer J. 2017, 7:e607. 10.1038\/bcj.2017.89","journal-title":"Blood Cancer J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26594","article-title":"Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement","volume":"64","author":"Zoghbi A","year":"2017","unstructured":"Zoghbi A, Zur Stadt U, Winkler B, M\u00fcller I, Escherich G. Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement. Pediatr Blood Cancer. 2017, 64:26504. 10.1002\/pbc.26594","journal-title":"Pediatr Blood Cancer"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmu.2017.02.001","article-title":"Lineage switch from acute lymphoblastic leukemia to myeloid leukemia","volume":"19","author":"Ruiz-Delgado GJ","year":"2017","unstructured":"Ruiz-Delgado GJ, Nu\u00f1ez-Cortez AK, Olivares-Gazca JC, Fortiz YC, Ruiz-Arg\u00fcelles A, Ruiz-Arg\u00fcelles GJ. Lineage switch from acute lymphoblastic leukemia to myeloid leukemia. Medicina Universitaria. 2017, 19:27-31. 10.1016\/j.rmu.2017.02.001","journal-title":"Medicina Universitaria"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7394619","article-title":"Immunotherapy- (blinatumomab-) related lineage switch of KMT2A\/AFF1 rearranged B-lymphoblastic leukemia into acute myeloid leukemia\/myeloid sarcoma and subsequently into B\/myeloid mixed phenotype acute leukemia","volume":"2019","author":"He RR","year":"2019","unstructured":"He RR, Nayer Z, Hogan M, et al.. Immunotherapy- (blinatumomab-) related lineage switch of KMT2A\/AFF1 rearranged B-lymphoblastic leukemia into acute myeloid leukemia\/myeloid sarcoma and subsequently into B\/myeloid mixed phenotype acute leukemia. Case Rep Hematol. 2019, 2019:7394619. 10.1155\/2019\/7394619","journal-title":"Case Rep Hematol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2019.05.02","article-title":"Lineage switch from T-cell lymphoblastic leukemia\/lymphoma to acute myeloid leukemia and back to T-cell lymphoblastic leukemia\/lymphoma in a patient diagnosed during pregnancy","volume":"6","author":"Aujla A","year":"2019","unstructured":"Aujla A, Hanmantgad M, Islam H, Shakil F, Liu D, Seiter K. Lineage switch from T-cell lymphoblastic leukemia\/lymphoma to acute myeloid leukemia and back to T-cell lymphoblastic leukemia\/lymphoma in a patient diagnosed during pregnancy. Stem Cell Investig. 2019, 6:12. 10.21037\/sci.2019.05.02","journal-title":"Stem Cell Investig"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022490","article-title":"A case report of lineage switch from T-cell acute leukemia to B-cell acute leukemia","volume":"99","author":"Zhu Y","year":"2020","unstructured":"Zhu Y, Liu H, Zhang S, Liang Y, Xiao M, Hao Y, Guan Y. A case report of lineage switch from T-cell acute leukemia to B-cell acute leukemia. Medicine (Baltimore). 2020, 99:e22490. 10.1097\/MD.0000000000022490","journal-title":"Medicine (Baltimore)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1177\/10935266211001308","article-title":"Lineage switch in an infant B-lymphoblastic leukemia with t(1;11)(p32;q23); KMT2A\/EPS15, following blinatumomab therapy","volume":"24","author":"Du J","year":"2021","unstructured":"Du J, Chisholm KM, Tsuchiya K, et al.. Lineage switch in an infant B-lymphoblastic leukemia with t(1;11)(p32;q23); KMT2A\/EPS15, following blinatumomab therapy. Pediatr Dev Pathol. 2021, 24:378-82. 10.1177\/10935266211001308","journal-title":"Pediatr Dev Pathol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.799982","article-title":"Repeated lineage switches in an elderly case of refractory B-cell acute lymphoblastic leukemia with MLL gene amplification: a case report and literature review","volume":"12","author":"Takeda R","year":"2022","unstructured":"Takeda R, Yokoyama K, Fukuyama T, et al.. Repeated lineage switches in an elderly case of refractory B-cell acute lymphoblastic leukemia with MLL gene amplification: a case report and literature review. Front Oncol. 2022, 12:799982. 10.3389\/fonc.2022.799982","journal-title":"Front Oncol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.4103\/ijpm.ijpm_441_21","article-title":"Lineage switch of acute myeloid leukemia to T-cell acute lymphoblastic leukemia - a unique case report","volume":"66","author":"Jamil SF","year":"2023","unstructured":"Jamil SF, Sharma U, Singh C, Bansal S. Lineage switch of acute myeloid leukemia to T-cell acute lymphoblastic leukemia - a unique case report. Indian J Pathol Microbiol. 2023, 66:191-5. 10.4103\/ijpm.ijpm_441_21","journal-title":"Indian J Pathol Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417307-mixed-phenotype-acute-leukemia-transforming-into-acute-myelomonocytic-leukemia-aml-m4-a-case-report-and-therapeutic-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:17:33Z","timestamp":1762874253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417307-mixed-phenotype-acute-leukemia-transforming-into-acute-myelomonocytic-leukemia-aml-m4-a-case-report-and-therapeutic-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.96576","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,11]]}}}